Cite
Kandel P, Wallace MB, Stauffer J, et al. Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study. J Pancreat Cancer. 2018;4(1):88-94doi: 10.1089/pancan.2018.0011.
Kandel, P., Wallace, M. B., Stauffer, J., Bolan, C., Raimondo, M., Woodward, T. A., Gomez, V., Ritter, A. W., Asbun, H., & Mody, K. (2018). Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study. Journal of pancreatic cancer, 4(1), 88-94. https://doi.org/10.1089/pancan.2018.0011
Kandel, Pujan, et al. "Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study." Journal of pancreatic cancer vol. 4,1 (2018): 88-94. doi: https://doi.org/10.1089/pancan.2018.0011
Kandel P, Wallace MB, Stauffer J, Bolan C, Raimondo M, Woodward TA, Gomez V, Ritter AW, Asbun H, Mody K. Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study. J Pancreat Cancer. 2018 Nov 01;4(1):88-94. doi: 10.1089/pancan.2018.0011. eCollection 2018. PMID: 30631861; PMCID: PMC6319614.
Copy
Download .nbib